Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Peptides
    • Fake HIV Medications
      • Diverted HIV Meds on P2P platforms
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Poisonous cough syrup
    • Counterfeit Pill Crisis
  • Patients
    • About Counterfeits / Save Money Safely
    • Talk to Your Family
    • HIV/HEPC Patients
    • Foreign Online Pharmacies
    • Med spas
    • Mexican Pharmacies
  • Professionals
    • Law Enforcement
    • Pharmacists
    • Doctors
    • Prosecution Document Library
      • Cases we’re following
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Med spas
    • Illegal Pill Presses
    • Drug Importation
    • PBM under-reimbursement
    • FOIA-ed Materials
    • Events and briefings
  • About Us
    • Join Our Mailing List
    • PSM in the news
    • Press Releases
    • Members
    • PSM Leadership
    • Contact Us
Document Tags: 2:23-cr-00141-SDW, PDL Anise Kachadourian, PDL Frank Incognito, PDL Herceptin, PDL Investigational Drug Delivery, PDL Joel Lerner, PDL Jon Paul Dadaian, PDL Kadcyla, PDL Lucentis, PDL New Jersey, PDL Rituxan, PDL VRC Medical Services, PDL oncology drugs, PDL ophthalmology drugs, PDL wholesalers, information
Return to library

United States District Court
District of New Jersey

USA v Jon Paul Dadaian

Information

Filed May 2022

Read the document.

Dadaian-JP-info
© 2003-2026 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top